| Dr Danielle Elizabeth Hooker, PHARMD | |
|
7090 Highway 72 W, Huntsville, AL 35806-1728 | |
| (615) 871-2573 | |
| Not Available |
| Full Name | Dr Danielle Elizabeth Hooker |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 7090 Highway 72 W, Huntsville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760157804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 21882 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danielle Elizabeth Hooker, PHARMD 2150 Hughes Rd Unit 3001, Madison, AL 35758-6444 Ph: (334) 444-3082 | Dr Danielle Elizabeth Hooker, PHARMD 7090 Highway 72 W, Huntsville, AL 35806-1728 Ph: (615) 871-2573 |
News Archive
Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).
Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.
Researchers found working out in a group lowers stress by 26 percent and significantly improves quality of life, while those who exercise individually put in more effort but experienced no significant changes in their stress level and a limited improvement to quality of life, according to a study published in The Journal of the American Osteopathic Association.
The COVID-19 pandemic has notably taken a more significant toll on men compared to women, in terms of both disease severity and death. Now, a new study by researchers at the Icahn School of Medicine at Mount Sinai and published on the preprint server medRxiv in August 2020 confirms the increased risk that males have for death following COVID-19 while also highlighting worse outcomes in women with coronary artery disease, obesity, and hypoxia compared to men.
Galapagos NV announced today that it has started a Phase II clinical study for the Company's flagship program GLPG0259, a novel drug being developed for rheumatoid arthritis. In this clinical trial, the safety and efficacy of this novel candidate drug will be tested in RA patients. Galapagos plans to announce interim results by the middle of next year and complete the trial by the end of 2011.
› Verified 5 days ago
Dr. Lydell Collier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 444 Wynn Dr Nw, Huntsville, AL 35816 Phone: 256-837-6240 | |
Brian Doyle Brettel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2750 Carl T Jones Dr Se, Huntsville, AL 35802 Phone: 256-883-6295 | |
Jessica Dawn Maulick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1086 Jeff Rd Nw, Huntsville, AL 35806 Phone: 865-256-0351 | |
Mrs. Deborah Neir Clark, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2200 Sparkman Dr Nw, Huntsville, AL 35810 Phone: 256-852-1323 Fax: 256-859-5169 | |
Mrs. Susan Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3054 Leeman Ferry Rd Sw, Suite J-1, Huntsville, AL 35801 Phone: 256-881-5130 Fax: 256-885-2338 | |
Erica R Hoge, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12796 Bailey Cove Rd Se, Huntsville, AL 35803 Phone: 256-885-2161 Fax: 256-885-0397 | |
Sharon Barringer Rivette, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1209 Chesser Dr Se, Huntsville, AL 35803 Phone: 256-881-6007 |